Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Tumor treating fields: Will the evidence gap ever be filled?
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 14, 2026
Three-Discipline Collaborative Radiation Therapy (3DCRT) debate: Medical physics should focus less on geometric precision and more on biological outcomes.
Journal: Journal of applied clinical medical physics
Published: May 17, 2026
Gut-targeted strategies at the intersection of radiotherapy and immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: February 10, 2026
Challenges and Opportunities in Evaluating Novel Drug-Radiotherapy Combinations.
Journal: Cureus
Published: May 14, 2025
Cargo Cult Radiotherapy: The Illusion of Precision in Advanced Technologies.
Journal: Cureus
Published: November 22, 2024
Lessons Learned About Acute and Late Toxicity After Two Decades of Experience With Pancreatic SBRT.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: October 24, 2024
Survey of Changes in Absolute Lymphocyte Counts and Peripheral Immune Repertoire Diversity after External Beam Radiotherapy.
Journal: Radiation research
Published: January 05, 2024
Declarations of Independence: How Embedded Multicollinearity Errors Affect Dosimetric and Other Complex Analyses in Radiation Oncology.
Journal: International journal of radiation oncology, biology, physics
Published: May 26, 2023
RE: Venkatesulu et al. (Letter to the Editor).
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: December 08, 2022
Neoadjuvant mFOLFIRINOX vs mFOLFIRINOX Plus Radiotherapy in Patients With Borderline Resectable Pancreatic Cancer-The A021501 Trial.
Journal: JAMA oncology
Published: December 01, 2022
Evaluation of Adjuvant Chemotherapy Survival Outcomes Among Patients With Surgically Resected Pancreatic Carcinoma With Node-Negative Disease After Neoadjuvant Therapy.
Journal: JAMA surgery
Published: November 23, 2022
Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC.
Journal: JTO clinical and research reports
Published: May 20, 2022
Last Updated: 09/26/2026